Contrasting roles for Vα14⁺ natural killer T cells in a viral model for multiple sclerosis

References

• Amano M, Baumgarth N, Dick MD, Brossay L, Kronenberg M, Herzenberg LA, Strober S. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen: β2-microglobulin-dependent and independent forms. J Immunol 1998; 161: 1710–1717
   PubMed Web of Science ®Google Scholar
• Apostolou I, Takahama Y, Belmant C, Kawano T, Huerre M, Marchal G, Cui J, Taniguchi M, Nakauchi H, Fournié J-J, Kourilsky P, Gachelin G. Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A 1999; 96: 5141–5146
   PubMed Web of Science ®Google Scholar
• Araki M, Kondo T, Gumperz JE, Brenner MB, Miyake S, Yamamura T. Th2 bias of CD4+ NKT cells derived from multiple sclerosis in remission. Int Immunol 2003; 15: 279–288
   PubMed Web of Science ®Google Scholar
• Bannai M, Oya H, Kawamura T, Naito T, Shimizu T, Kawamura H, Miyaji C, Watanabe H, Hatakeyama K, Abo T. Disparate effect of beige mutation on cytotoxic function between natural killer and natural killer T cells. Immunology 2000; 100: 165–169
   PubMedGoogle Scholar
• Baron JL, Gardiner L, Nishimura S, Shinkai K, Locksley R, Ganem D. Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 2002; 16: 583–594
   PubMed Web of Science ®Google Scholar
• Berzofsky JA, Terabe M. NKT cells in tumor immunity: Opposing subsets define a new immunoregulatory axis. J Immunol 2008; 180: 3627–3635
   PubMed Web of Science ®Google Scholar
• Burdin N, Brossay L, Koezuka Y, Smiley ST, Grusby MJ, Gui M, Taniguchi M, Hayakawa K, Kronenberg M. Selective ability of mouse CD1 to present glycolipids: α-galactosylceramide specifically stimulates Vα14+ NK T lymphocytes. J Immunol 1998; 161: 3271–3281
   PubMed Web of Science ®Google Scholar
• Byrne P, McGuirk P, Todryk S, Mills KHG. Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells. Eur J Immunol 2004; 34: 2579–2588
   PubMed Web of Science ®Google Scholar
• Cavarra E, Martorana PA, de Santi M, Bartalesi B, Cortese S, Gambelli F, Lungarella G. Neutrophil influx into the lungs of beige mice is followed by elastolytic damage and emphysema. Am J Respir Cell Mol Biol 1999; 20: 264–269
   Google Scholar
• Chiba A, Kaieda S, Oki S, Yamamura T, Miyake S. The involvement of Vα14 natural killer T cells in the pathogenesis of arthritis in murine models. Arthritis Rheum 2005; 52: 1941–1948
   PubMedGoogle Scholar
• Chiba A, Oki S, Miyamoto K, Hashimoto H, Yamamura T, Miyake S. Suppression of collagen-induced arthritis by natural killer T cell activation with OCH, a sphingosine-truncated analog of α-galactosylceramide. Arthritis Rheum 2004; 50: 305–313
   PubMed Web of Science ®Google Scholar
• Cui J, Shin T, Kawano T, Sato H, Kondo E, Toura I, Kaneko Y, Koseki H, Kanno M, Taniguchi M. Requirement for Vα14 NKT cells in IL-12-mediated rejection of tumors. Science 1997; 278: 1623–1626
   PubMed Web of Science ®Google Scholar
• Dang Y, Beckers J, Wang C-R, Heyborne KD. Natural killer 1.1+ αβ T cells in the periimplantation uterus. Immunology 2000; 101: 484–491
   PubMedGoogle Scholar
• Exley MA, Bigley NJ, Cheng O, Tahir SMA, Smiley ST, Carter QL, Stills HF, Grusby MJ, Koezuka Y, Taniguchi M, Balk SP. 2001. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus (Erratum in J Leukoc Biol 2001, 70; 340). J Leukoc Biol 69: 713–718.
   PubMed Web of Science ®Google Scholar
• Furlan R, Bergami A, Cantarella D, Brambilla E, Taniguchi M, Dellabona P, Casorati G, Martino G. Activation of invariant NKT cells by αGalCer administration protects mice from MOG35-55-induced EAE: critical roles for administration route and IFN-γ. Eur J Immunol 2003; 33: 1830–1838
   PubMed Web of Science ®Google Scholar
• Gausling R, Trollmo C, Hafler DA. Decreases in interleukin-4 secretion by invariant CD4−CD8− Vα24JαQ T cells in peripheral blood of patients with relapsing-remitting multiple sclerosis. Clin Immunol 2001; 98: 11–17
   PubMed Web of Science ®Google Scholar
• Greenlee JE, Rose JW. Controversies in neurological infectious diseases. Semin Neurol 2000; 20: 375–386
   PubMed Web of Science ®Google Scholar
• Grubor-Bauk B, Simmons A, Mayrhofer G, Speck PG. Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant Vα14-Jα281 TCR. J Immunol 2003; 170: 1430–1434
   PubMed Web of Science ®Google Scholar
• Habu Y, Shinomiya N, Kinoshita M, Matsumoto A, Kawabata T, Seki S. Mice deficient in Vβ8+NKT cells are resistant to experimental hepatitis but are partially susceptible to generalised Shwartzman reaction. Clin Exp Med 2007; 7: 30–38
   Google Scholar
• Huber S, Sartini D, Exley M. Role of CD1d in coxsackievirus B3-induced myocarditis. J Immunol 2003; 170: 3147–3153
   Google Scholar
• Illés Z, Kondo T, Newcombe J, Oka N, Tabira T, Yamamura T. Differential expression of NK T cell Vα24JαQ invariant TCR chain in the lesions of multiple sclerosis and chronic inflammatory demyelinating polyneuropathy. J Immunol 2000; 164: 4375–4381
   PubMed Web of Science ®Google Scholar
• Ito T, Ishibashi K, Imai K, Koseki H, Ra C, Fernandez E, Kantake M, Saito T, Taniguchi M. Monoclonal antibody against murine T cell receptor Vα14 cross-reacts with human CD3ε and detects disulfide-linked dimeric form. Int Immunol 1991; 3: 991–995
   Google Scholar
• Jahng AW, Maricic I, Pedersen B, Burdin N, Naidenko O, Kronenberg M, Koezuka Y, Kumar V. Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis. J Exp Med 2001; 194: 1789–1799
   PubMed Web of Science ®Google Scholar
• Kaminsky SG, Nakamura I, Cudkowicz G. Selective defect of natural killer and killer cell activity against lymphomas in SJL mice: Low responsiveness to interferon inducers. J Immunol 1983; 130: 1980–1984
   Google Scholar
• Kaminsky SG, Nakamura I, Cudkowicz G. Genetic control of the natural killer cell activity in SJL and other strains of mice. J Immunol 1985; 135: 665–671
   Google Scholar
• Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Motoki K, Ueno H, Nakagawa R, Sato H, Kondo E, Koseki H, Taniguchi M. CD1d-restricted and TCR-mediated activation of Vα14 NKT cells by glycosylceramides. Science 1997; 278: 1626–1629
   PubMed Web of Science ®Google Scholar
• Kawano T, Cui J, Koezuka Y, Toura I, Kaneko Y, Sato H, Kondo E, Harada M, Koseki H, Nakayama T, Tanaka Y, Taniguchi M. Natural killer-like nonspecific tumor cell lysis mediated by specific ligand-activated Vα14 NKT cells. Proc Natl Acad Sci U S A 1998; 95: 5690–5693
   PubMed Web of Science ®Google Scholar
• Kim BS, Fuller AC, Koh C-S. Cytokines, chemokines and adhesion molecules in TMEV-IDD. Experimental models of multiple sclerosis, E Lavi, CS Constantinescu. Springer Science + Business Media, New York 2005; 659–671
   Google Scholar
• Levy O, Orange JS, Hibberd P, Steinberg S, LaRussa P, Weinberg A, Wilson SB, Shaulov A, Fleisher G, Geha RS, Bonilla FA, Exley M. Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells. J Infect Dis 2003; 188: 948–953
   PubMed Web of Science ®Google Scholar
• Makino Y, Kanno R, Ito T, Higashino K, Taniguchi M. Predominant expression of invariant Vα14+ TCR α chain in NK1.1+ T cell populations. Int Immunol 1995; 7: 1157–1161
   Google Scholar
• Mars LT, Laloux V, Goude K, Desbois S, Saoudi A, Van Kaer L, Lassmann H, Herbelin A, Lehuen A, Liblau RS. Vα14-Jα281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice. J Immunol 2002; 168: 6007–6011
   PubMed Web of Science ®Google Scholar
• McCright IJ, Tsunoda I, Whitby FG, Fujinami RS. Theiler's viruses with mutations in loop I of VP1 lead to altered tropism and pathogenesis. J Virol 1999; 73: 2814–2824
   Google Scholar
• Mieza MA, Itoh T, Cui JQ, Makino Y, Kawano T, Tsuchida K, Koike T, Shirai T, Yagita H, Matsuzawa A, Koseki H, Taniguchi M. Selective reduction of Vα14+ NK T cells associated with disease development in autoimmune-prone mice. J Immunol 1996; 156: 4035–4040
   PubMedGoogle Scholar
• Miyake S, Yamamura T. Therapeutic potential of glycolipid ligands for natural killer (NK) T cells in the suppression of autoimmune diseases. Curr Drug Targets- Immune Endocr Metab Disord 2005; 5: 315–322
   PubMedGoogle Scholar
• Miyamoto K, Miyake S, Yamamura T. A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 2001; 413: 531–534
   PubMed Web of Science ®Google Scholar
• Nakagawa R, Nagafune I, Tazunoki Y, Ehara H, Tomura H, Iijima R, Motoki K, Kamishohara M, Seki S. Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J Immunol 2001; 166: 6578–6584
   PubMed Web of Science ®Google Scholar
• Paya CV, Patick AK, Leibson PJ, Rodriguez M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J Immunol 1989; 143: 95–102
   PubMed Web of Science ®Google Scholar
• Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634–642
   PubMed Web of Science ®Google Scholar
• Potvin DM, Metzger DW, Lee WT, Collins DN, Ramsingh AI. Exogenous interleukin-12 protects against lethal infection with coxsackievirus B4. J Virol 2003; 77: 8272–8279
   Web of Science ®Google Scholar
• Rigaud S, Fondanéche M-C, Lambert N, Pasquier B, Mateo V, Soulas P, Galicier L, Le Deist F, Rieux-Laucat F, Revy P, Fischer A, de Saint Basile G, Latour S. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 2006; 444: 110–114
   PubMed Web of Science ®Google Scholar
• Rose JW, Watt HE, White AT, Carlson NG. Treatment of multiple sclerosis with an anti-interleukin-2 receptor monoclonal antibody. Ann Neurol 2004; 56: 864–867
   PubMed Web of Science ®Google Scholar
• Schofield L, McConville MJ, Hansen D, Campbell AS, Fraser-Reid B, Grusby MJ, Tachado SD. CD1d-restricted immunoglobulin G formation to GPI-anchored antigens mediated by NKT cells. Science 1999; 283: 225–229
   PubMed Web of Science ®Google Scholar
• Serizawa I, Koezuka Y, Amao H, Saito TR, Takahashi KW. Functional natural killer T cells in experimental mouse strains, including NK1.1− strains. Exp Anim 2000; 49: 171–180
   Google Scholar
• Sharif S, Arreaza GA, Zucker P, Mi Q-S, Delovitch TL. Regulation of autoimmune disease by natural killer T cells. J Mol Med 2002; 80: 290–300
   Google Scholar
• Singh AK, Wilson MT, Hong S, Olivares-Villagómez D, Du C, Stanic AK, Joyce S, Sriram S, Koezuka Y, Van Kaer L. Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis. J Exp Med 2001; 194: 1801–1811
   PubMed Web of Science ®Google Scholar
• Singh AK, Yang J-Q, Parekh VV, Wei J, Wang C-R, Joyce S, Singh RR, Van Kaer L. The natural killer T cell ligand α-galactosylceramide prevents or promotes pristane-induced lupus in mice. Eur J Immunol 2005; 35: 1143–1154
   PubMed Web of Science ®Google Scholar
• Slifka MK, Pagarigan RR, Whitton JL. NK markers are expressed on a high percentage of virus-specific CD8+ and CD4+ T cells. J Immunol 2000; 164: 2009–2015
   PubMed Web of Science ®Google Scholar
• Taniguchi M, Makino Y, Cui J, Masuda K, Kawano T, Sato H, Kondo E, Koseki H. Vα14+ NK T cells: A novel lymphoid cell lineage with regulatory function. J Allergy Clin Immunol 1996; 98: S263–S269
   Google Scholar
• Taniguchi M, Seino K, Nakayama T. The NKT cell system: bridging innate and acquired immunity. Nat Immunol 2003; 4: 1164–1165
   PubMed Web of Science ®Google Scholar
• Teige A, Teige I, Lavasani S, Bockermann R, Mondoc E, Holmdahl R, Issazadeh-Navikas S. CD1-dependent regulation of chronic central nervous system inflammation in experimental autoimmune encephalomyelitis. J Immunol 2004; 172: 186–194
   PubMed Web of Science ®Google Scholar
• Trambley J, Bingaman AW, Lin A, Elwood ET, Waitze S-Y, Ha J, Durham MM, Corbascio M, Cowan SR, Pearson TC, Larsen CP. Asialo GM1+ CD8+ T cells play a critical role in costimulation blockade-resistant allograft rejection. J Clin Invest 1999; 104: 1715–1722
   PubMedGoogle Scholar
• Tsunoda I, Fujinami RS. Theiler's murine encephalomyelitis virus. Persistent viral infections, R Ahmed, ISY Chen. John Wiley & Sons, Chichester, West SussexEngland 1999; 517–536
   Google Scholar
• Tsunoda I, Kuang L-Q, Theil DJ, Fujinami RS. Antibody association with a novel model for primary progressive multiple sclerosis: Induction of relapsing-remitting and progressive forms of EAE in H2s mouse strains. Brain Pathol 2000; 10: 402–418
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Libbey JE, Kuang L-Q, Terry EJ, Fujinami RS. Massive apoptosis in lymphoid organs in animal models for primary and secondary progressive multiple sclerosis. Am J Pathol 2005; 167: 1631–1646
   Google Scholar
• Tsunoda I, Tanaka T, Saijoh Y, Fujinami RS. Targeting inflammatory demyelinating lesions to sites of Wallerian degeneration. Am J Pathol 2007a; 171: 1563–1575
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Tanaka T, Terry EJ, Fujinami RS. Contrasting roles for axonal degeneration in an autoimmune versus viral model for multiple sclerosis: When can axonal injury be beneficial?. Am J Pathol 2007b; 170: 214–226
   PubMed Web of Science ®Google Scholar
• Tsunoda I, Wada Y, Libbey JE, Cannon TS, Whitby FG, Fujinami RS. Prolonged gray matter disease without demyelination caused by Theiler's murine encephalomyelitis virus with a mutation in VP2 puff B. J Virol 2001; 75: 7494–7505
   Google Scholar
• Tsunoda I, Tanaka T, Fujinami RS. Regulatory role of CD1d in neurotropic virus infection. J Virol 2008; 82: 10279–10289
   PubMedGoogle Scholar
• van der Vliet HJJ, von Blomberg BME, Nishi N, Reijm M, Voskuyl AE, van Bodegraven AA, Polman CH, Rustemeyer T, Lips P, van den Eertwegh AJM, Giaccone G, Scheper RJ, Pinedo HM. Circulating Vα24+ Vβ11+ NKT cell numbers are decreased in a wide variety of diseases that are characterized by autoreactive tissue damage. Clin Immunol 2001; 100: 144–148
   PubMed Web of Science ®Google Scholar
• Van Kaer L. NKT cells: T lymphocytes with innate effector functions. Curr Opin Immunol 2007; 19: 354–364
   PubMed Web of Science ®Google Scholar
• Yamamura T, Sakuishi K, Illés Z, Miyake S. Understanding the behavior of invariant NKT cells in autoimmune diseases. J Neuroimmunol 2007; 191: 8–15
   PubMed Web of Science ®Google Scholar
• Yoshimoto T, Bendelac A, Hu-Li J, Paul WE. Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T cells that promptly produce interleukin 4. Proc Natl Acad Sci U S A 1995; 92: 11931–11934
   PubMed Web of Science ®Google Scholar